Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer – A systematic review and meta-analysis
Chemotherapy was associated with higher survival in patients with T1bN0 TNBC, but not in patients with T1aN0 tumors. Overall, 5-year outcomes were high even without chemotherapy. These findings support current guideline recommendations.
Authors
- Carsten Bogh Juhl (ORCID: https://orcid.org/0000-0001-8456-5364)
- N. Kroman
- Iben Kümler (ORCID: https://orcid.org/0000-0001-5082-3660)
- Tove Holst Filtenborg Tvedskov
- Ann Søegaard Knoop
- Dorte Lisbet Nielsen
- Christina M.S. Hassing
Institutions
- Herlev Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Critical Reviews in Oncology/Hematology
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1016/j.critrevonc.2026.105225
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gentofte Hospital
- Helsefonden